First Health Pharmaceuticals B Vis A Biotech Company With Its Main Offices In Amsterdamthe Netherlandsconsidering The Groundbreaking Nature Of The Rna Helicase Targeting Technologydeveloped By Our Groupand The Vast Array Of Pathogens And Malignancies That Is Targeted By Our Compoundsit Will Come As No Surprise That Many Research Groups Worldwidedirectly Or Indirectlyparticipated In The Research In Our Field Of Interestsome Of These Collaborations Are Based On A Joint Development Agreement But Most Academic Groups Performed Efficacy Tests Related To Pathogens That Fit Their Field Of Research Purely For Academic Reasonsthese Collaborations Are Of Mutual Benefitour Research Group Is The Only One In The World That Developed A Large Portfolio Of Small Molecule Ddx3 Helicase Inhibitorsfor Use Both Asantivirals And Anti Tumor Agentsas Suchmany Highly Specialised Research Groups Around The World Are Interested In Testing Our Compoundsin Order To Gain More Insight In The Complex Cellular Rna Helicase Biochemistryrelated To The Pathogens They Are Working Onwefrom Our Sidealso Learn Many New Things About Our Field Of Researchbut Even In Cases In Which No Direct Benefit Is To Be Expected For Our Companywe Still Aim To Satisfy All Requests That Reach Us From Interested Academic Groupsplease Visit Our Website For More Information Http Firsthealthpharma Com
